These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7644663

  • 1. Epinephrine administration for severe adverse reactions to contrast agents.
    Samett EJ, Espinosa GA.
    Radiology; 1995 Sep; 196(3):879. PubMed ID: 7644663
    [No Abstract] [Full Text] [Related]

  • 2. Fatal Anaphylaxis Associated With the Gadolinium-Based Contrast Agent Gadoteridol (ProHance).
    Takahashi S, Takada A, Saito K, Hara M, Yoneyama K, Nakanishi H.
    J Investig Allergol Clin Immunol; 2015 Sep; 25(5):366-7. PubMed ID: 26727767
    [No Abstract] [Full Text] [Related]

  • 3. Adverse reaction to intravenous gadoteridol.
    Shellock FG, Hahn HP, Mink JH, Itskovich E.
    Radiology; 1993 Oct; 189(1):151-2. PubMed ID: 8372186
    [Abstract] [Full Text] [Related]

  • 4. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ, Anzai LL.
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [Abstract] [Full Text] [Related]

  • 5. Severe anaphylactoid shock secondary to gadolinium contrast media.
    Simons CW, Benouni S, Gibbon G, Klaustermeyer W.
    Ann Allergy Asthma Immunol; 2009 Oct; 103(4):359-60. PubMed ID: 19852205
    [No Abstract] [Full Text] [Related]

  • 6. Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging.
    Lukawska J, Mandaliya D, Chan AWE, Foggitt A, Bidder T, Harvey J, Stycharczuk L, Bisdas S.
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1086-1087. PubMed ID: 30217530
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute renal failure after arteriography with a gadolinium-based contrast agent.
    Gemery J, Idelson B, Reid S, Yucel EK, Pagan-Marin H, Ali S, Casserly L.
    AJR Am J Roentgenol; 1998 Nov; 171(5):1277-8. PubMed ID: 9798860
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical Safety of Gadoteridol, Representative of the Macrocyclic Class of Gadolinium-Based Contrast Agents.
    Runge VM.
    J Magn Reson Imaging; 2020 Mar; 51(3):869-870. PubMed ID: 31614049
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anaphylaxis manifested by hypotension alone.
    Viner NA, Rhamy RK.
    J Urol; 1975 Jan; 113(1):108-10. PubMed ID: 1113380
    [Abstract] [Full Text] [Related]

  • 15. Considerations in the choice of contrast media for MR imaging.
    Brasch RC, Bennett HF.
    Radiology; 1988 Mar; 166(3):897-9. PubMed ID: 3340795
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
    Tardy B, Guy C, Barral G, Page Y, Ollagnier M, Bertrand JC.
    Lancet; 1992 Feb 22; 339(8791):494. PubMed ID: 1346846
    [No Abstract] [Full Text] [Related]

  • 20. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV, Panov OV, Egorova SV, Bolotova EN, Shimanovskii NL, Akhadov TA, Sviridov NK.
    Vestn Rentgenol Radiol; 1997 Feb 22; (1):45-52. PubMed ID: 9133071
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.